As of 2026-03-22, the Relative Valuation of Inozyme Pharma Inc (INZY) is (33.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -934.8%.
The range of the Relative Valuation is (30.28) - (35.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 22.6x | 20.0x |
| Forward P/E multiples | 17.5x - 21.2x | 20.4x |
| Fair Price | (30.28) - (35.11) | (33.39) |
| Upside | -857.1% - -977.7% | -934.8% |
| Date | P/E |